Table 2 Differentially expressed miRNAs (fold change > 2 or < 0.5) induced by TAB administration in sevoflurane-treated PC12 cells

From: Protective role of trametenolic acid B against sevoflurane-induced cognitive impairments by its different regulatory modalities of mir-329-3p in neurons and microglia

miRNAs	TAB–	TAB+	Fold change
Upregulated
rno–miR–22–3p	0.93	4.51	4.85
rno–miR–381	1.12	4.60	4.11
rno–miR–452–5p	1.25	4.56	3.65
rno–miR–130a–3p	0.55	1.57	2.85
rno–miR–216–5p	0.63	1.74	2.76
rno–miR–103	0.33	0.71	2.16
rno–miR–135a–5p	2.75	5.61	2.04
Downregulated
rno–miR–199a–5p	1.94	0.66	0.34
rno–miR–329–3p	2.89	1.01	0.35
rno–miR–144–3p	2.56	1.08	0.42
rno–miR–181d–5p	1.85	0.89	0.48
rno–miR–429–3p	1.32	0.65	0.49

Back to article page